DRUG testing specialist Cyprotex has struck a new deal with pharmaceutical giant Pfizer.The Macclesfield firm's US-based Apredica subsdiary, which it acquired in 2010, will take part in an 18-month collaborative research project with Pfizer.The firm said the collaboration was a research-based project which aims to, "evaluate, further develop, and improve several of Cyprotex's proprietary offerings in the area of predictive toxicology".  Chief executive Dr Anthony Baxter said: "We are delighted to be able to continue our relati......for the full story register now for free or login below...